With technological, research, and theoretical advancements, the amount of data being generated for analysis is growing rapidly. In many cases, the number of subjects may be small, but the number of measurements taken on each subject may be very large. Consider, for example, two groups of patients. The subjects in one group are diseased and the other subjects are not. Over 9,000 relative fluorescent unit (RFU) signals, measures of the presence and abundance of proteins, are collected in a microarray or protoarray from each subject. Typically these kind of data show marked skewness (departure from normality) which invalidates standard multivariate normal-based theory. What is more, due to the cost involved, only a limited number of subjects c...